Oncolytics Biotech ONCY
NASDAQ ONCY
$0.41 +0.03 (+7.81%)
At close: Nov 11, 2026 · 4:00 PM EST

Oncolytics Biotech (ONCY) Beginning Cash Balance (2015)

Updated

Oncolytics Biotech (ONCY) reported Beginning Cash Balance of $11.11 million for Q1 2025, down 57.1% from $25.91 million a year earlier.

Analysis

Oncolytics Biotech (ONCY) Beginning Cash Balance (2015) Analysis & Trends

For FY2024, Oncolytics Biotech posted Beginning Cash Balance of $25.5 million, up 194.9% from FY2023.

  • Beginning Cash Balance has a five-year compound annual growth rate of 19.8% (FY2019 to FY2024).
  • By year, Beginning Cash Balance came in at $8.65 million in FY2023 (-72.8%), $31.74 million in FY2022 (+27.4%), $24.91 million in FY2021 (+135.9%) and $10.56 million in FY2020 (+2.3%).
  • The Q1 2025 figure ranks as the lowest quarterly Beginning Cash Balance since Q1 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Oncolytics Biotech 47.36 Mn 23.68 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2015 19.27 Mn
API Access

Oncolytics Biotech Beginning Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=beginning-cash-balance&ticker=ONCY&period=max&api_key=YOUR_API_KEY